Author

P. Taneja

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:cell type annotation· 1 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1 Organism:E. coli· 1 Research Focus:gene regulatory network inference· 1 Assay:proteomics· 1

Frequent Co-Authors

A. E. Nebyou· 1 shared B. Z. Sibuh· 1 shared M. G. Sanal· 1 shared N. Vats· 1 shared S. K. Sarin· 1 shared S. K. Venugopal· 1 shared S. Khanna· 1 shared S. P. Sharma· 1 shared

Activity by Year

2020-2020 · peak 3/yr

Co-Author Collaboration Network

8 top collaborators · 8 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. E. Nebyou

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cloning of Human ABCB11 Gene in E. coli required the removal of an Intragenic Pribnow-Schaller Box before its Insertion into Genomic Safe Harbor AAVS1 Site using CRISPR Cas9

N. Vats, M. G. Sanal, S. K. Venugopal, P. Taneja, S. K. Sarin

The paper inserts the human ABCB11 gene into the AAVS1 site in HEK 293T cells using CRISPR-Cas9, but reports low homologous recombination efficiency.

bioRxiv · Sep 5, 2020Cell Biology

Anti-microbial activity of potential probiotic lactic acid bacteria against Methicillin-Resistant Staphylococcus Aureus (MRSA)

A. E. Nebyou, S. P. Sharma, P. Taneja

This study evaluates the probiotic potential of lactic acid bacteria isolates from bovine milk by testing their acid and bile tolerance, BSH activity, and antimicrobial activity against MRSA.

bioRxiv · Mar 8, 2020 · PreprintMicrobiology

Effects of substituents on anticancer activity of thiosemicarbazone against MCF-7 human breast cancer cell line

B. Z. Sibuh, P. Taneja, S. Khanna

This study evaluates the in-vitro anticancer activity of various thiosemicarbazones against MCF-7 breast cancer cells and normal MCF-10 cells, finding dose- and substituent-dependent effects with some compounds showing selectivity.

bioRxiv · Feb 19, 2020Cancer Biology